EBAY
45
2
AEE
38
-12
XEL
50
-3
CVX
28
3
VRSK
84
-5
ROK
50
2
CMA
50
10
UNM
63
2
AN
47
3
STT
40
-8
HP
44
3
SE
49
-6
ABBV
68
2
VIX
25
4
TAP
43
2
PDCO
60
2
LEN
50
2
CA
32
-4
PG
51
-5
DFS
57
4
EBAY
45
2
AEE
38
-12
XEL
50
-3
CVX
28
3
VRSK
84
-5
ROK
50
2
CMA
50
10
UNM
63
2
AN
47
3
STT
40
-8
HP
44
3
SE
49
-6
ABBV
68
2
VIX
25
4
TAP
43
2
PDCO
60
2
LEN
50
2
CA
32
-4
PG
51
-5
DFS
57
4
Financhill
Back

Keros Therapeutics Vs. Biomarin Pharmaceutical Industry Stock Comparison

Sell
27

KROS
Keros Therapeutics

Last Price:
45.71
Seasonality Move:
-4.71%
Buy
58

BMRN
Biomarin Pharmaceutical

Last Price:
82.34
Seasonality Move:
3.62%
Sell
27
Keros Therapeutics (KROS) is a Sell

Is Keros Therapeutics a Buy, Sell or Hold?

  • The current Keros Therapeutics [KROS] share price is $45.70. The Score for KROS is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
  • KROS is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
58
Biomarin Pharmaceutical (BMRN) is a Buy

Is Biomarin Pharmaceutical a Buy, Sell or Hold?

  • The current Biomarin Pharmaceutical [BMRN] share price is $82.37. The Score for BMRN is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.
  • BMRN is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

KROS Stock Price Chart

What is Keros Therapeutics's stock price today?

  • The Keros Therapeutics share price today is $45.70
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and KROS is experiencing slight buying pressure.

BMRN Stock Price Chart

What is Biomarin Pharmaceutical's stock price today?

  • The Biomarin Pharmaceutical share price today is $82.37
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BMRN is experiencing selling pressure, which indicates risk of future bearish movement.

KROS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.79 Sell
Relative Strength Index (14 RSI): 38.41 Sell
Chaikin Money Flow: 239305 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (45.72 - 49.1) Sell
Bollinger Bands (100): (49.87 - 64.91) Sell

BMRN Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 1.01 Buy
Relative Strength Index (14 RSI): 49.61 Sell
Chaikin Money Flow: -1165158 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (77.07 - 84.93) Buy
Bollinger Bands (100): (80.21 - 89.17) Sell

KROS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 45.61 Buy
20-day SMA: 47.29 Sell
50-day SMA: 51.65 Sell
200-day SMA: 47.07 Sell
8-day EMA: 45.93 Sell
20-day EMA: 47.34 Sell
50-day EMA: 50.89 Sell
200-day EMA: 50 Sell

BMRN Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 84.23 Sell
20-day SMA: 82.49 Sell
50-day SMA: 81.75 Buy
200-day SMA: 87.14 Sell
8-day EMA: 83.8 Sell
20-day EMA: 82.79 Sell
50-day EMA: 82.7 Sell
200-day EMA: 86.62 Sell

Keros Therapeutics Earnings Growth & KROS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.06 per share, an increase next quarter of $0.03 per share, an increase this year of $0.35 per share, and a decrease next year of $0.39 per share.

Biomarin Pharmaceutical Earnings Growth & BMRN Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.27 per share, an increase next quarter of $0.27 per share, an increase this year of $0.84 per share, and an increase next year of $0.97 per share.

Keros Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Biomarin Pharmaceutical Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):